Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-45l2p Total loading time: 0 Render date: 2024-04-26T18:55:40.526Z Has data issue: false hasContentIssue false

Chapter 2 - The Inpatient with Depression

Published online by Cambridge University Press:  05 March 2020

Michael I. Casher
Affiliation:
University of Michigan
Joshua D. Bess
Affiliation:
University of Michigan
Get access

Summary

Most patients with uncomplicated depression can be treated as an outpatient, while inpatient care is generally reserved for people with severe or treatment-resistant depressive symptoms, significantly impaired reality testing due to accompanying psychosis, high suicide risk, and/or impaired self-care [1]. Many patients whose initial presentation is so severe as to warrant hospitalization will have “failed” outpatient treatment. Even though such patients already have an established outpatient team, the inpatient psychiatrist should be prepared to reevaluate the patient’s diagnosis and overall plan as part of a “fresh look,” and attempt to understand why the patient is not responding well to outpatient treatment.

Treatment-refractory depression patients are also sometimes referred for hospital admission with a specific plan for initiation of a course of electroconvulsive therapy (ECT) [2].

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

George, L, Durbin, J, Sheldon, T, Goering, P. Patient and contextual factors related to the decision to hospitalize patients from emergency psychiatric services. Psychiatric Services 2002;53(12):1586–91.Google Scholar
Fink, M, Abrams, R, Bailine, S, Jaffe, R. Ambulatory electroconvulsive therapy: report of a task force of the association for convulsive therapy. Association for Convulsive Therapy 1996;12(1):4255.Google Scholar
Jones, A, Crossley, D. “In the mind of another”– shame and acute psychiatric inpatient care: an exploratory study. A report on phase one: service users. Journal of Psychiatric and Mental Health Nursing 2008;15(9):749–57.Google Scholar
Engel, G. The clinical application of the biopsychosocial model. American Journal of Psychiatry 1980;137(5):535–44.Google Scholar
Engel, GL. The need for a new medical model: a challenge for biomedicine. Science 1977;196(4286):129–36.Google Scholar
Mahoney, JS, Palyo, N, Napier, G, Giordano, J. The therapeutic milieu reconceptualized for the 21st century. Archives of Psychiatric Nursing 2009;23(6):423–9.Google Scholar
Schopp, R. Depression, the insanity defense, and civil commitment: foundations in autonomy and responsibility. International Journal of Law and Psychiatry 1989;12(1):8198.Google Scholar
Treatment Advocacy Center. State Standards for Assisted Treatment: State by State Chart: Treatment Advocacy Center; 2008 [updated September 2008]. Available from: www.treatmentadvocacycenter.org.Google Scholar
Caplan, JP. Mnemonics in a mnutshell: 32 aids to psychiatric diagnosis. Current Psychiatry 2008;7(10):2733.Google Scholar
Sajatovic, M, Ramirez, L. Rating scales in mental health. 2nd ed. Hudson, Ohio: Lexi-Comp, Inc.; 2003.Google Scholar
Maixner, D. “Beyond The DSM” – A lecture on descriptive psychopathology. Ann Arbor, MI, 2005.Google Scholar
Parker, G. Is the diagnosis of melancholia important in shaping clinical management? Current Opinion in Psychiatry 2007;20(3):197–201. doi:10.1097/YCO.0b013e3280ad43f0.CrossRefGoogle ScholarPubMed
Nelson, JC, Davis, JM. DST studies in psychotic depression: a meta-analysis. American Journal of Psychiatry 1997;154(11):1497–503.Google Scholar
Antonijevic, IA. Depressive disorders – is it time to endorse different pathophysiologies? Psychoneuroendocrinology 2006;31(1):115.CrossRefGoogle ScholarPubMed
Perry, PJ. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. Journal of Affective Disorders 1996;39(1):16.CrossRefGoogle ScholarPubMed
Thase, ME. Bipolar depression: diagnostic and treatment considerations. Development and Psychopathology 2006;18(4):1213–30.Google Scholar
Taylor, MA, Fink, M. Restoring melancholia in the classification of mood disorders. Journal of Affective Disorders 2008;105(1–3):114.Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
Fink, M, Taylor, MA. Catatonia: a clinician’s guide to diagnosis and treatment. Cambridge, UK: Cambridge University Press; 2003.CrossRefGoogle Scholar
Kim, J, Khoury, R, Grossberg, G. Botulinum toxin: emerging psychiatric indications. Current Psychiatry 2018;17(12):817.Google Scholar
Marcus, S, Flynn, H, Young, E, Ghaziuddin, N, Mudd, S. Recurrent depression in women throughout the life span. In: Greden, J, ed. Review of psychiatry vol 20: treatment of recurrent depression. Washington DC: American Psychiatric Publishing, Inc.; 2001: 1958.Google Scholar
Kahn, MW. Emergency psychiatry: tools of engagement: avoiding pitfalls in collaborating with patients. Psychiatric Services 2001;52(12):1571–2.CrossRefGoogle ScholarPubMed
Bollini, P, Pampallona, S, Kupelnick, B, Tibaldi, G, Munizza, C. Improving compliance in depression: a systematic review of narrative reviews. Journal of Clinical Pharmacy and Therapeutics 2006;31(3):253–60.CrossRefGoogle ScholarPubMed
Blazer, DG. Depression in late life: review and commentary. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2003;58(3):249–65.Google Scholar
Gallo, J, Rabins, P, Lyketsos, C, Tien, A, Anthony, J. Depression without sadness: functional outcomes of nondysphoric depression in later life. Journal of the American Geriatrics Society 1997;45(5):5708.CrossRefGoogle ScholarPubMed
Chopra, MP, Sullivan, JR, Feldman, Z, Landes, RD, Beck, C. Self-, collateral- and clinician assessment of depression in persons with cognitive impairment. Aging & Mental Health 2008;12(6):675–83.Google Scholar
Goodwin, F, Jamison, K. Children and adolescents. In: Manic-depressive illness bipolar disorders and recurrent depression. 2nd ed. New York: Oxford University Press; 2007: 187221.Google Scholar
Levenson, J. Essentials of psychosomatic medicine. Arlington, VA.: American Psychiatric Publishing, Inc.; 2007.Google Scholar
Andreasen, NC, Swayze, V, 2nd, Flaum, M, Alliger, R, Cohen, G. Ventricular abnormalities in affective disorder: clinical and demographic correlates. American Journal of Psychiatry 1990;147(7):893900.Google Scholar
Herrmann, LL, Le Masurier, M, Ebmeier, KP. White matter hyperintensities in late life depression: a systematic review. Journal of Neurology, Neurosurgery & Psychiatry 2008;79(6):619–24.Google ScholarPubMed
Pompili, M, Innamorati, M, Mann, JJ, et al. Periventricular white matter hyperintensities as predictors of suicide attempts in bipolar disorders and unipolar depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2008;32(6):1501–7.Google Scholar
Videbech, P, Ravnkilde, B, Fiirgaard, B, et al. Structural brain abnormalities in unselected in-patients with major depression. Acta Psychiatrica Scandinavica 2001;103(4):282–6.Google Scholar
Lieberman, DZ, Resnik, HL, Holder-Perkins, V. Environmental risk factors in hospital suicide. Suicide and Life-Threatening Behavior 2004;34(4):448–53.Google Scholar
Busch, K, Fawcett, J, Jacobs, D. Clinical correlates of inpatient suicide. Journal of Clinical Psychiatry 2003;64(1):1419.Google Scholar
Angst, J, Angst, F, Stassen, HH. Suicide risk in patients with major depressive disorder. Journal of Clinical Psychiatry 1999;60 (Suppl 2): 5762;discussion 75–6, 113–16.Google Scholar
Burgess, P, Pirkis, J, Morton, J, Croke, E. Lessons from a comprehensive clinical audit of users of psychiatric services who committed suicide. Psychiatric Services 2000;51(12):1555–60.Google Scholar
Pirkis, J, Burgess, P. Suicide and recency of health care contacts: a systematic review. British Journal of Psychiatry 1998;173:462–74.Google Scholar
Goodwin, FK. Preventing inpatient suicide. Journal of Clinical Psychiatry 2003;64(1):12–3.Google Scholar
Shea, SC. The practical art of suicide assessment: a guide for mental health professionals and substance abuse counselors. New York: John Wiley; 1999.Google Scholar
Powell, J, Geddes, J, Hawton, K, Deeks, J, Goldacre, M. Suicide in psychiatric hospital in-patients: risk factors and their predictive power. The British Journal of Psychiatry 2000;176(3):266–72.CrossRefGoogle ScholarPubMed
Tishler, CL, Reiss, NS. Inpatient suicide: preventing a common sentinel event. General Hospital Psychiatry 2009;31(2):103–9.Google Scholar
Miller, M, Hemenway, D. Guns and suicide in the United States. The New England Journal of Medicine 2008;359(10):989–91.Google Scholar
Appleby, L. Suicide in psychiatric patients: risk and prevention. British Journal of Psychiatry 1992;161(6):749–58.Google Scholar
Malone, KM, Oquendo, MA, Haas, GL, et al. Protective factors against suicidal acts in major depression: reasons for living. American Journal of Psychiatry 2000;157(7):1084–8.Google Scholar
Berlim, MT, Turecki, G. What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. European Neuropsychopharmacology 2007;17(11):696707.Google Scholar
Pridmore, S, Turnier-Shea, Y. Medication options in the treatment of treatment-resistant depression. Australian and New Zealand Journal of Psychiatry 2004;38(4):219–25.Google Scholar
Fagiolini, A, Kupfer, DJ. Is treatment-resistant depression a unique subtype of depression? Biological Psychiatry 2003;53(8):640–8.Google Scholar
ten Doesschate, MC, Bockting, CLH, Schene, AH. Adherence to continuation and maintenance antidepressant use in recurrent depression. Journal of Affective Disorders 2009;115(1–2):167–70.Google Scholar
Frye, MA, Ketter, TA, Leverich, GS, et al. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. Journal of Clinical Psychiatry 2000;61(1):915.CrossRefGoogle ScholarPubMed
Coutts, RT, Urichuk, LJ. Polymorphic cytochromes P450 and drugs used in psychiatry. Cellular & Molecular Neurobiology 1999;19(3):325–54.Google Scholar
Tanaka, E, Hisawa, S. Clinically significant pharmacokinetic drug interactions with psychoactive drugs: antidepressants and antipsychotics and the cytochrome P450 system. Journal of Clinical Pharmacy & Therapeutics 1999;24(1):716.Google Scholar
Vandel, P, Talon, JM, Haffen, E, Sechter, D. Pharmacogenetics and drug therapy in psychiatry – the role of the CYP2D6 polymorphism. Current Pharmaceutical Design 2007;13(2):241–50.Google Scholar
Thase, ME. The role of axis II comorbidity in the management of patients with treatment-resistant depression. Psychiatric Clinics of North America 1996;19(2):287309.CrossRefGoogle ScholarPubMed
Hammen, C. Stress and depression. Annual Review of Clinical Psychology 2005;1(1):293319.Google Scholar
Monroe, SM, Reid, MW. Life stress and major depression. Current Directions in Psychological Science 2009;18(2):6872.Google Scholar
Tennant, C. Life events, stress and depression: a review of recent findings. Australian and New Zealand Journal of Psychiatry 2002;36(2):173–82.CrossRefGoogle ScholarPubMed
Thase, ME, Howland, RH. Refractory depression: relevance of psychosocial factors and therapies. Psychiatric Annals 1994;24:232–40.Google Scholar
Akiskal, HS, Akiskal, HS. Searching for behavioral indicators of bipolar II in patients presenting with major depressive episodes: the “red sign,” the “rule of three” and other biographic signs of temperamental extravagance, activation and hypomania. Journal of Affective Disorders 2005;84(2–3):279–90.Google Scholar
Ghaemi, SN, Rosenquist, KJ, Ko, JY, Baldassano, CF, Kontos, NJ, Baldessarini, RJ. Antidepressant treatment in bipolar versus unipolar depression. American Journal of Psychiatry 2004;161(1):163–5.Google Scholar
Thase, M. Treatment-resistant depression and the bipolar spectrum: recognition and management. Primary Psychiatry 2006;13(11):5967.Google Scholar
Sachs, GS, Nierenberg, AA, Calabrese, JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. New England Journal of Medicine 2007;356(17):1711–22.Google Scholar
Rothschild, AJ, Winer, J, Flint, AJ, et al. Missed diagnosis of psychotic depression at 4 academic medical centers. Journal of Clinical Psychiatry 2008;69(8):1293–6.Google Scholar
Gournellis, RTK, Touloumi, G, Thomadakis, C, et al. Psychotic (delusional) depression and completed suicide: a systematic review and meta-analysis. Annals of General Psychiatry 2018;17(39): available at https://doi.org/10.1186/s12991-018–0207-1.Google Scholar
Abrams, R, Taylor, MA. Catatonia. A prospective clinical study. Archives of General Psychiatry 1976;33(5):579–81.Google Scholar
Carroll, BT, Anfinson, TJ, Kennedy, JC, et al. Catatonic disorder due to general medical conditions. Journal of Neuropsychiatry & Clinical Neurosciences 1994;6(2):122–33.Google Scholar
Joseph, R. Frontal lobe psychopathology: mania, depression, confabulation, catatonia, perseveration, obsessive compulsions, and schizophrenia. Psychiatry 1999;62(2):138–72.Google Scholar
Rosebush, PI, Hildebrand, AM, Furlong, BG, Mazurek, MF. Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam. Journal of Clinical Psychiatry 1990;51(9):357–62.Google Scholar
Taylor, MA, Fink, M. Catatonia in psychiatric classification: a home of its own American Journal of Psychiatry 2003;160(7):1233–41.CrossRefGoogle ScholarPubMed
Bush, G, Fink, M, Petrides, G, Dowling, F, Francis, A. Catatonia. II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatrica Scandinavica 1996;93(2):137–43.Google Scholar
American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 2nd ed. Washington, DC: American Psychiatric Association; 2000.Google Scholar
Suehs, B, Argo, T, Bendele, S, et al. Texas medication algorithm project procedural manual – major depressive disorder algorithms. 2008 [updated August 6, 2008]. Available from: https://web.archive.org/web/20041016094947/http://www.dshs.state.tx.us/mhprograms/TIMA.shtm.Google Scholar
Rush, AJ, Trivedi, MH, Wisniewski, SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry 2006;163(11):1905–17.Google Scholar
Bauer, MMDP, Pfennig, AMDM, Linden, MMDP, et al. Efficacy of an algorithm-guided treatment compared with treatment as usual: a randomized, controlled study of inpatients with depression. Journal of Clinical Psychopharmacology 2009;29(4):327–33.Google Scholar
Trivedi, MH, Rush, AJ, Crismon, ML, et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Archives of General Psychiatry 2004;61(7):669–80.CrossRefGoogle ScholarPubMed
Gartlehner, G, Gaynes, BN, Hansen, RA, et al. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Annals of Internal Medicine 2008;149(10):734–50.CrossRefGoogle ScholarPubMed
Qaseem, A, Snow, V, Denberg, TD, Forciea, MA, Owens, DK. Using second-generation antidepressants to treat depressive disorders: a clinical practice guideline from the American College of Physicians. Annals of Internal Medicine 2008;149(10):725–33.Google Scholar
Cipriani, A, Furukawa, TA, Salanti, G, et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009;373(9665):746–58.Google Scholar
Papakostas, G, Fava, M, Thase, M. Treatment of SSRI-resistant depression: a meta-analysis comparing within-versus across-class switches. Biological Psychiatry 2008;63(7):699704.Google Scholar
Nemeroff, CB, Entsuah, R, Benattia, I, et al. Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. Biological Psychiatry 2008;63(4):424–34.Google Scholar
Rush, AJ, Trivedi, MH, Wisniewski, SR, et al. Bupropion-SR, Sertraline, or Venlafaxine-XR after failure of SSRIs for depression. The New England Journal of Medicine 2006;354(12):1231–42.Google Scholar
Weinmann, S, Becker, T, Koesters, M. Re-evaluation of the efficacy and tolerability of venlafaxine vs. SSRI: meta-analysis. Psychopharmacology 2008;196(4):511–20.Google Scholar
Kelsey, JE. Dose-response relationship with venlafaxine. Journal of Clinical Psychopharmacology 1996;16(3 Suppl 2):21S26S.Google Scholar
Vanoli, A, Lane, C, Harrison, C, Steen, N, Young, A. Adequacy of venlafaxine dose prescribing in major depression and hospital resources implications. Journal of Psychopharmacology 2008;22(4):434–40.Google Scholar
Fava, M, Rush, A, Wisniewski, S, et al. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR* D report. American Journal of Psychiatry 2006;163(7):1161–72.Google Scholar
Quitkin, F, Taylor, B, Kremer, C. Does mirtazapine have a more rapid onset than SSRIs? Journal of Clinical Psychiatry 2001;62(5):358–61.Google Scholar
Wheatley, D, Van Moffaert, M, Timmerman, L, Kremer, C. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Journal of Clinical Psychiatry 1998;59(6):306–12.Google Scholar
Gillman, PK. Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. British Journal of Pharmacology 2007;151(6):737–48.Google Scholar
Krishnan, KR. Revisiting monoamine oxidase inhibitors. Journal of Clinical Psychiatry 2007;68 (Suppl 8):3541.Google Scholar
McGrath, PJ, Stewart, JW, Fava, M, et al. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. American Journal of Psychiatry 2006;163(9):1531–41.Google Scholar
Shulman, K, Walker, S. A reevaluation of dietary restrictions for irreversible monoamine oxidase inhibitors. Psychiatric Annals 2001;31(6):378–84.Google Scholar
Fava, M, Rush, A. Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice. Psychotherapy and Psychosomatics 2006;75(3):139–53.Google Scholar
Zajecka, J. Strategies for the treatment of antidepressant-related sexual dysfunction. Journal of Clinical Psychiatry 2001;62 (Suppl 3):3543.Google Scholar
Nelson, JC, Mazure, CM, Jatlow, PI, Bowers, MB, Jr., Price, LH. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study. Biological Psychiatry 2004;55(3):296300.Google Scholar
Goldberg, RS, Thornton, WE. Combined tricyclic-MAOI therapy for refractory depression: a review, with guidelines for appropriate usage. Journal of Clinical Pharmacology 1978;18(2–3):143–7.Google Scholar
White, K, Simpson, G. Combined MAOI-tricyclic antidepressant treatment: a reevaluation. Journal of Clinical Psychopharmacology 1981;1(5):264–82.Google Scholar
Nierenberg, AA, Fava, M, Trivedi, MH, et al. A comparison of lithium and T3 augmentation following two failed medication treatments for depression: a STAR*D report. American Journal of Psychiatry 2006;163(9):1519–30.Google Scholar
Kelly, TF, Lieberman, DZ. Long term augmentation with T3 in refractory major depression. Journal of Affective Disorders 2009;115(1–2):230–3.Google Scholar
Nelson, JC, Papakostas, GI. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. American Journal of Psychiatry 2009;166(9):980–91.Google Scholar
Birkenhager, TK, Pluijms, EM, Lucius, SAP. ECT response in delusional versus non-delusional depressed inpatients. Journal of Affective Disorders 2003;74(2):191–5.Google Scholar
Meyers, BS, Flint, AJ, Rothschild, AJ, et al. A double-blind randomized controlled trial of olanzapine plus sertraline vs. olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Archives of General Psychiatry 2009;66(8):838–47.Google Scholar
Bunney, W, Murphy, D, Goodwin, F, Borge, G. The switch process from depression to mania: relationship to drugs which alter brain amines. Lancet 1970;1(655):1022–7.Google Scholar
Maixner, D, Taylor, M. Section I – The efficacy and safety of electroconvulsive therapy. In: Tyrer, P, Silk, K, eds. Cambridge textbook of effective treatments in psychiatry. Cambridge: Cambridge University Press; 2008.Google Scholar
American Psychiatric Association, Committee on Electroconvulsive Therapy, Weiner RD. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging: a task force report of the American Psychiatric Association. 2nd ed. Washington, DC: American Psychiatric Association; 2001.Google Scholar
Scott, A. The ECT handbook. London: Royal College of Psychiatrists; 2005.Google Scholar
Anderson, EL, Reti, IM. ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosomatic Medicine 2009;71(2):235–42.Google Scholar
Kelly, K, Zisselman, M. Update on electroconvulsive therapy (ECT) in older adults. Journal of the American Geriatrics Society 2000;48(5):560–6.Google Scholar
Perera, T, George, MS, Grammer, G, et al. The Clinical TMS Society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain Stimulation 2016;9(3):336–46.Google Scholar
Janicak, PG, Dokucu, ME. Transcranial magnetic stimulation for the treatment of major depression. Neuropsychiatric Disease and Treatment 2015;11:1549–60.Google Scholar
Epstein, CM, Wassermann, EM, Ziemann, U. Oxford handbook of transcranial stimulation. Oxford: Oxford University Press; 2008.Google Scholar
Andrade, C. Ketamine for depression, 1: clinical summary of issues related to efficacy, adverse effects, and mechanism of action. Journal of Clinical Psychiatry 2017;78(4):e415e419.Google Scholar
Andrade, C. Ketamine for depression, 4: in what dose, at what rate, by what route, for how long, and at what frequency? Journal of Clinical Psychiatry 2017;78(7):e852e857.Google Scholar
Al Shirawi, MI, Kennedy, SH, Ho, KT, Byrne, R, Downar, J. Oral ketamine in treatment-resistant depression: a clinical effectiveness case series. Journal of Clinical Psychopharmacology 2017;37(4):464–7.Google Scholar
Vanina Popova, MD, Ella, J. Daly, MD, et al. Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study. American Journal of Psychiatry 2019;176(6):428–38.Google Scholar
Kanes, S, Colquhoun, H, Gunduz-Bruce, H, et al. Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet 2017;390(10093):480–9.Google Scholar
Casher, MI, Schuldt, S, Haq, A, Burkhead-Weiner, D. Chronotherapy in treatment-resistant depression. Psychiatric Annals 2012;42(5):166–9.Google Scholar
Dallaspezia, S, Suzuki, M, Benedetti, F. Chronobiological therapy for mood disorders. Current Psychiatry Reports 2015;17(12):95.Google Scholar
Sit, DK, McGowan, J, Wiltrout, C, et al. Adjunctive bright light therapy for bipolar depression: a randomized double-blind placebo-controlled trial. American Journal of Psychiatry 2018;175(2):131–9.Google Scholar
Wu, JC, Kelsoe, JR, Schachat, C, et al. Rapid and sustained antidepressant response with sleep deprivation and chronotherapy in bipolar disorder. Biological Psychiatry 2009;66(3):298301.Google Scholar
Beck, A. Cognitive therapy and the emotional disorders. New York: International University Press; 1976.Google Scholar
Durrant, C CI, Tolland, A, Wilson, H, Trust, N, Trust, H. Designing a CBT service for an acute inpatient setting: a pilot evaluation study. Clinical Psychology and Psychotherapy 2007;19(1):4250.Google Scholar
Stuart, S WJ, Thase, M, Beck, A. Cognitive therapy with inpatients. General Hospital Psychiatry 1997;19(1):4250.Google Scholar
Elkin, I. The NIMH treatment of depression collaborative research program: where we began and where we are. In: Bergin, A, Garfield, S, eds. Handbook of Psychotherapy and Behaviour Change. New York: Wiley; 1994.Google Scholar
Schramm, E, van Calker, D, Dykierek, P, et al. An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results. American Journal of Psychiatry 2007;164(5):768–77.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×